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Abstract
Background: BIR family proteins are evolutionarily conserved anti-apoptotic molecules. One
member of Xenopus BIR family proteins, xEIAP/XLX, is a weak apoptosis inhibitor and rapidly
degraded in a cell-free apoptotic execution system derived from interphase egg extracts. However,
unfertilized eggs are naturally arrested at the metaphase of meiosis II by the concerted activities of
Mos-MEK-p42MAPK-p90Rsk kinase cascade (cytostatic factor pathway) and many mitotic kinases.
Previous studies suggest that cytostatic factor-arrested egg extracts are more resistant to
spontaneous apoptosis than interphase egg extracts in a p42MAPK-dependent manner. We tested
whether xEIAP/XLX might be phosphorylated in cytostatic factor-arrested egg extracts, and also
examined whether xEIAP/XLX could be functionally regulated by phosphorylation.
Results: We found that p42MAPK was the major kinase phosphorylating xEIAP/XLX in cytostatic
factor-arrested egg extracts, and three Ser residues (Ser 235/251/254) were identified as
p42MAPK-mediated phosphorylation sites. We characterized the behaviors of various xEIAP/XLX
mutants that could not be phosphorylated by p42MAPK. However, neither protein stability nor
anti-apoptotic ability of xEIAP/XLX was significantly altered by the substitution of Ser with either
Ala or Asp at these three sites.
Conclusion: xEIAP/XLX is physiologically phosphorylated by p42MAPK in Xenopus unfertilized
eggs. However, this protein may not serve as an essential mediator of p42MAPK-dependent anti-
apoptotic activity.
Background
In various animal species including Xenopus, ovulated
mature eggs have to survive without the support of sur-
rounding follicle cells until successful fertilization. In con-
trast with the long life of immature oocytes in ovary, the
life of ovulated mature eggs is limited to only a few days.
Many reports indicate that aged eggs without fertilization
or parthenogenetically activated eggs eventually die by
apoptosis [reviewed in [1-3]]. Although the exhaustion of
nutrients can contribute to oocyte/egg apoptosis [4], the
mechanism of this machinery is still poorly understood.
The translation of Mos protein kinase begins during
oocyte maturation and automatically activates Mos-MEK-
ERK (p42MAPK in Xenopus  oocyte)-p90Rsk kinase cas-
cade. This is called CSF (cytostatic factor) pathway
because its primary role is to arrest the cell cycle until fer-
tilization [reviewed in [5,6]]. In vertebrates, CSF arrests
mature eggs at the metaphase of meiosis II, and many
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mitotic kinases including Cdc2/cyclin B are also kept
active. Recent studies suggest that CSF pathway also regu-
lates apoptosis [7-11], but the exact targets are largely
unknown.
Baculovirus IAP repeat (BIR) family proteins are evolu-
tionarily conserved zinc-coordinating proteins, and some
members inhibit apoptosis by blocking caspase activities
[reviewed in [12,13]]. We recently identified four BIR fam-
ily proteins in Xenopus eggs and examined their apoptosis-
inhibiting activities using a cell-free system derived from
interphase egg extracts [11]. Whereas xXIAP was a physio-
logical apoptosis inhibitor, xEIAP (identical with XLX
reported by Holley et al. [14]) only weakly inhibited
apoptosis, and neither xSurvivin1/xBIR1 nor xSurvivin2/
SIX showed anti-apoptotic activities. However, both CSF
and mitotic kinases are inactive in interphase egg extracts,
and we wondered whether BIR family proteins might be
functionally regulated by phosphorylation in CSF-
arrested egg extracts. We found that p42MAPK directly
phosphorylated xEIAP/XLX on three Ser residues in the
Ser-rich region between BIR2 and RING finger domains in
CSF-arrested egg extracts. The effects of phosphorylation
on the stability and anti-apoptotic activity of xEIAP/XLX
were also examined.
Results and Discussion
Phosphorylation-dependent electrophoretic mobility shift 
of xEIAP/XLX in CSF-arrested egg extracts
As previously reported, recombinant xEIAP/XLX is rapidly
degraded by at least two distinct, consecutively acting pro-
teolytic systems [11,14]. Within 2 h incubation, xEIAP/
XLX is significantly degraded in both CSF-arrested and
interphase egg extracts in a C-terminal RING finger-
dependent manner. Subsequently, spontaneous cyto-
chrome c-induced caspase activation begins after 4 h incu-
bation in interphase egg extracts (apoptotic egg extracts),
and the remaining xEIAP/XLX is cleaved by the activated
caspases at yet unidentified site(s). This caspase activation
is delayed or suppressed in CSF-arrested egg extracts by a
p42MAPK-dependent pathway [7-11]. We found that the
electrophoretic mobilities of recombinant 6XHis-tagged
(6XHis-FL) and MBP-tagged (MBP-FL) xEIAP/XLX slightly
decreased during incubation in CSF-arrested but not inter-
phase egg extracts (Fig. 1B), whereas those of other BIR
family proteins (xSurvivin1/xBIR1, xSurvivin2/SIX, and
xXIAP) did not (data not shown). However, the rapid deg-
radation of both 6XHis-FL and MBP-FL in egg extracts
hampered the detailed analysis of this shift. Thus, we also
used the C-terminally truncated stabilized forms of
xEIAP/XLX [11]. MBP-Δ1, consisting of residues 1–269 of
xEIAP/XLX, showed a marked upward shift in CSF-
arrested but not interphase egg extracts. In contrast, the
electrophoretic mobility of MBP-Δ2 consisting of residues
1–218 of xEIAP/XLX did not change in both extracts (Fig.
1B). To confirm that upward shift in CSF-arrested egg
extracts was due to phosphorylation, endogenous xEIAP/
XLX was immunoprecipitated from CSF-arrested egg
extracts and then treated with alkaline phosphatase. As
shown in Fig. 1C, the phosphatase treatment increased
the electrophoretic mobility of endogenous xEIAP/XLX,
indicating that the upward shift was indeed induced by
phosphorylation. These results suggest that the region
encompassing residues 219–269 of xEIAP/XLX contains
CSF-phosphorylation site(s). We also found that, in apop-
totic egg extracts, MBP-fused recombinants generated sev-
eral shorter fragments, most likely produced by caspase-
mediated cleavages [11,14]. The larger fragment (~70k,
single asterisk) was slightly smaller than MBP-Δ1, whereas
the smaller fragments (50–55k, double asterisks) were
close to the parental MBP (45k). The cleavage of MBP-Δ2,
which was smaller than the larger fragment, produced
only the smaller fragments. Our data indicate that xEIAP/
XLX is cleaved at several sites, one of which locates
between the residues 219–269. It should be noted that
our Western blot detected only the MBP-fused N-terminal
fragments but not the released C-terminal fragments. We
did not observe any cleavage products of radiolabeled
6XHis-FL, suggesting that the generated C-terminal frag-
ments might be further degraded.
Phosphorylation of xEIAP/XLX by p42MAPK in CSF-
arrested egg extracts
To identify the kinase(s) phosphorylating xEIAP/XLX, we
next tested various protein kinase inhibitors in the assay
using MBP-Δ1 as substrate. The presence of 100 μM rosco-
vitine, a specific Cdk inhibitor, could not block the
upward shift of MBP-Δ1 (Fig. 2A). In contrast, 100 μM
U0126, a specific inhibitor for MEK and thereby an indi-
rect inhibitor for downstream p42MAPK and p90Rsk, par-
tially inhibited the change of electrophoretic mobility.
Staurosporine, a general protein kinase inhibitor, com-
pletely blocked the shift when supplied to CSF-arrested
egg extracts at 10 μM (Fig. 2A). This result indicated that
CSF pathway was involved in xEIAP/XLX phosphoryla-
tion. It should be noted that the complete inhibition of
already activated p42MAPK and 90Rsk requires not only
MEK inhibition but also the dephosphorylation of these
kinases. The partial inhibition by U0126 suggests that
xEIAP/XLX may be phosphorylated by downstream
p42MAPK and/or p90Rsk rather than MEK itself. Indeed,
recombinant p42MAPK phosphorylated MBP-Δ1, but not
MBP-Δ2, in vitro (Fig. 2B, MAPK). In contrast, neither sub-
strate was phosphorylated by immunoprecipitated Cdc2/
Cyclin B2 complex (Fig. 2B, Cdc2). In control reactions,
p42MAPK selectively phosphorylated myelin basic pro-
tein but not histone H1, whereas Cdc2/Cyclin B2 strongly
phosphorylated both substrates. Similarly, MBP-Δ1, his-
tone H1, and myelin basic protein, but not MBP-Δ2, were
phosphorylated in CSF-arrested (Fig. 2B, CSF) but notBMC Biochemistry 2007, 8:5 http://www.biomedcentral.com/1471-2091/8/5
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interphase egg extracts (Fig, 2B, INT). Altogether, we con-
clude that xEIAP/XLX is directly phosphorylated by
p42MAPK in CSF-arrested egg extracts.
p42MAPK phosphorylates Ser235/251/254 of xEIAP/XLX
The optimal sequence for MAPK-mediated phosphoryla-
tion is Pro-Xaa-(Xaa)-Ser/Thr-Pro and the minimal
sequence requirement is Ser/Thr-Pro. There are five Ser-
Pro-Xaa-Ser repeats within the residues 219–269 of
xEIAP/XLX, three of which (Ser235/251/254) fulfil opti-
mal MAPK consensus (Fig. 3A). Although another opti-
mal MAPK consensus site resides inside the first BIR
domain of xEIAP/XLX (Ser58), this residue may not be
recognized because MBP-Δ2 was not phosphorylated by
p42MAPK (Fig. 2B). As C-terminal region absent in MBP-
Δ1 (residues 270–401) contains no MAPK consensus site,
MBP-Δ1 is a suitable substrate to study the phosphoryla-
tion of xEIAP/XLX by p42MAPK. We first tried to evaluate
the phosphorylation of individual Ser residues by Ala sub-
stitution, with closely located Ser251 and Ser254 mutated
together. We analyzed the p42MAPK-mediated phospho-
rylation of WT, Ser235Ala single mutant (1A), Ser251/
254Ala double mutant (2A), and Ser235/251/254Ala tri-
ple mutant (3A). As shown in Fig. 3B, 1A and 2A muta-
tions led to 11% and 34% reductions of phosphorylation,
respectively. The decrease of phosphorylation in 3A
mutant (49%) was close to the sum of decreases in 1A and
2A mutants (45%), suggesting that these residues were
independently phosphorylated. However, 3A mutant was
still significantly phosphorylated, probably at Ser231/
247, both in CSF-arrested extracts and by recombinant
p42MAPK (Fig. 3C). Interestingly, when the same three
Ser residues were changed to Asp (3D), this mutant was
not phosphorylated at all (Fig. 3C). The most straightfor-
ward interpretation of these data may be that Ser235/251/
254 are the primary residues targeted by p42MAPK. The
remaining residues were phosphorylated in 3A mutant
but not in 3D mutant, presumably because the net charges
also affected the phosphorylation status of xEIAP/XLX.
The introduction of negative charges by p42MAPK-medi-
ated phosphorylation may be limited to at most three sites
under physiological condition, and remaining two resi-
dues can be phosphorylated only when Ser235/251/254
are substituted to neutral residues.
Phosphorylation of Ser235/251/254 affects neither protein 
stability nor apoptosis-inhibiting activity of xEIAP/XLX
We next tested whether the substitutions of p42MAPK
phosphorylation sites could affect the electrophoretic
mobility, protein stability, and anti-apoptotic functions
of xEIAP/XLX. For 6XHis-FL, MBP-FL, and MBP-Δ1, the
upward band shift of WT observed in CSF-arrested egg
extracts was reduced in 3A mutants and blocked in 3D
mutants (Fig. 4A). Moreover, the larger cleavage product
(single asterisk) in apoptotic egg extracts was slightly
Phosphorylation-dependent electrophoretic mobility shift of  xEIAP/XLX in CSF-arrested egg extracts Figure 1
Phosphorylation-dependent electrophoretic mobil-
ity shift of xEIAP/XLX in CSF-arrested egg extracts. 
(A) Schematic models of recombinant proteins used in this 
study. (B) Time-dependent changes of recombinant proteins 
incubated in CSF-arrested (CSF) and interphase (INT) egg 
extracts. 35S-radiolabeled 6XHis-FL, MBP-FL, MBP-Δ1, and 
MBP-Δ2 were mixed with either CSF-arrested or interphase 
egg extracts and incubated for indicated time periods (0, 2, 
and 4 h). After separation by SDS-PAGE, radiolabeled and 
MBP-fused recombinants were detected by image analyzer 
and Western blot, respectively. Molecular weights of stand-
ard proteins are indicated at the left. The larger (~70 k) and 
smaller cleavage products (50–55 k) of MBP-fusions are indi-
cated by single and double asterisks, respectively. (C) Phos-
phorylation-dependent electrophoretic mobility shift of 
xEIAP/XLX. Endogenous xEIAP/XLX in CSF-arrested egg 
extracts were retrieved by antibody-coated beads and incu-
bated with (+) or without (-) calf intestine alkaline phos-
phatase. After separation by SDS-PAGE, xEIAP/XLX was 
detected by Western blot. Positions of phosphorylated (P-
xEIAP) and unphosphorylated (xEIAP) forms of xEIAP/XLX 
are indicated by arrowheads. The position of IgG heavy chain 
(IgG HC) is indicated by the line.BMC Biochemistry 2007, 8:5 http://www.biomedcentral.com/1471-2091/8/5
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decreased in MBP-FL 3D mutant and absent in MBP-Δ1
3D mutant. If we assume that this fragment is produced
by caspase-mediated cleavage after Asp, the cleavage site
may be Asp237 and the introduction of negative charge at
Ser235 may inhibit caspase recognition especially in MBP-
Δ1. However, the smaller fragments of MBP-FL and MBP-
Δ1 (double asterisks) were equally observed in all the
three recombinant forms. Thus, although MBP-Δ1 was
stabilized by 3D mutation against caspase-mediated
cleavage in apoptotic egg extracts, the overall stabilities of
6XHis-FL and MBP-FL were not significantly altered by 3A
or 3D mutation in both egg extracts, indicating that the
alterations of p42MAPK recognition sites did not modify
the stability of xEIAP/XLX in egg extracts. Next, we asked
whether the apoptosis-inhibiting activity of xEIAP/XLX is
affected by the same substitutions. As previously
described, the time-dependent fragmentation of sperm
nuclei is the hallmark of apoptosis execution in inter-
phase egg extracts [11,16-18]. The addition of MBP-xXIAP
strongly inhibited nuclear fragmentation (positive con-
trol) compared to non-fused MBP (negative control). All
xEIAP/XLX recombinants did not inhibit apoptosis signif-
icantly in our experiments, either in the presence (MBP-
FL; Fig. 4B) or absence (MBP-Δ1; Fig. 4C) of RING finger-
containing C-terminus. Similar results were obtained in
CSF-arrested egg extracts, as judged from the caspase-
dependent cleavage of endogenous p150Glued at 6–8 h
(nuclear morphology could not be analyzed because of
mitotic chromatin condensation, data not shown). More-
over, we previously reported that the immunodepletion
of xEIAP/XLX from either CSF-arrested or interphase egg
extracts showed no effect on apoptotic execution [11].
Altogether, we conclude that neither protein stability nor
apoptosis-inhibiting activity of xEIAP/XLX is affected by
p42MAPK-mediated phosphorylation.
Conclusion
Our data indicate that, although xEIAP/XLX is a physio-
logically phosphorylatable substrate for p42MAPK, it may
not be a direct mediator of p42MAPK-dependent anti-
apoptotic activity in CSF-arrested egg extracts. One possi-
ble role of xEIAP/XLX might be to titrate or ubiquitylate
pro-apoptotic molecules, thereby indirectly supporting
the anti-apoptotic role of xXIAP [19-23]. Otherwise,
xEIAP/XLX could regulate the abundance of xXIAP [24-
26] or ubiquitylate apoptotic signal transducers [22,27-
30]. Further studies to address these issues are currently in
progress. During the preparation of this manuscript,
Greenwood and Gautier also reported that xEIAP/XLX is
phosphorylated mainly by MAPK during meiosis [31].
Methods
Preparation of recombinant proteins
Vector construction, bacterial expression and affinity puri-
fication of maltose binding protein (MBP)-fused recom-
binant proteins were previously described [11]. In vitro
translation of 35S-radiolabeled 6XHis-tagged recombinant
proteins in rabbit reticulocyte lysates using TnT T7 Quick
(Promega, Tokyo, Japan) and Pro-Mix (GE Healthcare,
Tokyo, Japan) was carried out according to manufacture's
instructions. Site-directed mutagenesis was performed
using QuikChange (Stratagene, CA, USA) and confirmed
by DNA sequencing.
Preparation of Xenopus egg extracts
Preparations of CSF-arrested, interphase, and apoptotic
egg extracts were previously described [11,15-18]. Where
indicated, roscovitine (Calbiochem-Merck, Tokyo,
Phosphorylation of xEIAP/XLX by p42MAPK in CSF-arrested  egg extracts Figure 2
Phosphorylation of xEIAP/XLX by p42MAPK in CSF-
arrested egg extracts. (A) The effects of kinase inhibitors. 
MBP-Δ1 was incubated in CSF-arrested (CSF) and interphase 
(INT) egg extracts, respectively, with or without the indi-
cated kinase inhibitors (R, 100 μM roscovitine; U, 100 μM 
U0126; S, 10 μM staurosporine) for indicated time periods (0 
and 2 h). After separation by SDS-PAGE, MBP-Δ1 was 
detected by Western blot. (B) Phosphorylation of xEIAP/
XLX by p42MAPK and CSF-arrested egg extracts. MBP-Δ1, 
MBP-Δ2, and control substrates Histone H1 and myelin basic 
protein (Myelin BP) were incubated with Cdc2/Cyclin B2 
(Cdc2), p42MAPK (MAPK), CSF-arrested (CSF) egg extracts, 
or interphase (INT) egg extracts in the presence of [γ-32P] 
ATP. After separation by SDS-PAGE, incorporated radioac-
tivity was detected by image analyzer.BMC Biochemistry 2007, 8:5 http://www.biomedcentral.com/1471-2091/8/5
Page 5 of 7
(page number not for citation purposes)
Japan), U0126 (Sigma-Aldrich, Tokyo, Japan), and stau-
rosporine (Sigma-Aldrich) were supplied to egg extracts.
Protein stability assay
MBP-fused recombinants were added to egg extracts at 1
μg/ml, whereas rabbit reticulocyte lysates containing radi-
olabeled recombinants were mixed with egg extracts at
1:9. After incubation, samples were resolved by SDS-
PAGE, and remaining MBP-fused and radiolabeled
recombinants were detected by Western blot using anti-
MBP antiserum (New England Biolabs, MA, USA) and by
BAS-5000 image analyzer (Fuji Film, Tokyo, Japan),
respectively.
Protein phosphorylation assay
Recombinant activated p42MAPK was purchased from
New England Biolabs. Active Cdc2/Cyclin B2 complex
was immunoprecipitated from CSF-arrested egg extracts
by affinity-purified anti-Xenopus  Cyclin B2 antibody
immobilized on Affi-Prep Protein A beads (Bio-Rad,
Tokyo, Japan). Histone H1 and myelin basic protein were
purchased from Roche (Tokyo, Japan) and Sigma-Aldrich,
respectively. Kinase assay using purified p42MAPK and
Cdc2/Cyclin B2 was performed in 10 μl of Assay Buffer
(10 mM HEPES-KOH, pH 7.7, 15 mM MgCl2, 1 mM DTT)
containing respective kinase, 1 μg of substrate protein,
100 μM cold ATP, and 37 kBq of [γ-32P] ATP (GE Health-
care). For phosphorylation assay by egg extracts, either
CSF-arrested or interphase egg extracts were first diluted 5-
fold with MEB-TX (20 mM HEPES-KOH, pH 7.7, 15 mM
MgCl2, 80 mM sodium glycerol 2-phosphate, 20 mM
EGTA, 1 mM DTT, 0.2 mM phenylmethanesulfonyl fluo-
ride, 0.1% Triton X-100). Diluted extracts were then sup-
plied with 1 μg of substrate protein and 37 kBq of [γ-32P]
ATP in 10 μl. After the reaction at 30°C for 30 min, sam-
ples were resolved by SDS-PAGE and analyzed with image
analyzer.
Dephosphorylation of endogenous xEIAP/XLX
Affinity-purified anti-xEIAP/XLX antibody was first
immobilized on Affi-Prep Protein A beads and then mixed
with CSF-arrested egg extracts to retrieve endogenous
xEIAP/XLX. After extensive washing, the xEIAP/XLX-
loaded beads in Assay Buffer were incubated with calf
p42MAPK phosphorylates Ser235/251/254 of xEIAP/XLX Figure 3
p42MAPK phosphorylates Ser235/251/254 of xEIAP/XLX. (A) Amino acid sequence of xEIAP/XLX residues 219–269. 
Indicated three Ser residues are changed to either Ala or Asp. (B) Phosphorylation of WT, Ser235Ala single mutant (1A), 
Ser251/254Ala double mutant (2A), and Ser235/251/254Ala triple mutant (3A). (C) Phosphorylation of WT, 3A, and Ser235/
251/254Asp triple mutant (3D). In (B) and (C), MBP-Δ1 variants were incubated with CSF-arrested egg extracts (CSF) or 
p42MAPK (MAPK) in the presence of [γ-32P] ATP. After separation by SDS-PAGE, incorporated radioactivity was detected by 
image analyzer. Same amounts of substrates were also stained with Coomassie Brilliant Blue (Input). In (B), the phosphoryla-
tion intensities were calculated using NIH ImageJ software and indicated below.BMC Biochemistry 2007, 8:5 http://www.biomedcentral.com/1471-2091/8/5
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Phosphorylation of Ser235/251/254 affects neither protein stability nor apoptosis-inhibiting activity of xEIAP/XLX Figure 4
Phosphorylation of Ser235/251/254 affects neither protein stability nor apoptosis-inhibiting activity of xEIAP/
XLX. (A) Stability and electrophoretic mobility shift of xEIAP/XLX. The WT/3A/3D forms of 35S-radiolabeled 6XHis-FL, MBP-
FL, and MBP-Δ1 were incubated in CSF-arrested (CSF) or interphase (INT) egg extracts for indicated time periods (0, 2, and 4 
h). After separation by SDS-PAGE, radiolabeled and MBP-fused recombinants were detected by image analyzer and Western 
blot, respectively. Molecular weights of standard proteins are indicated at the left. The larger (~70 k) and smaller cleavage 
products (50–55 k) of MBP-fusions are indicated by single and double asterisks, respectively. (B) Apoptosis inhibition by MBP-
FL. (C) Apoptosis inhibition by MBP-Δ1. In (B) and (C), nuclear fragmentation assays were carried out as previously described 
[11]. Open circles, MBP (negative control); closed circles, WT; open triangles, 3A; closed triangles, 3D; open squares, MBP-
xXIAP (positive control). Data are represented as mean + S.E.M. (N = 5).Publish with BioMed Central    and   every 
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intestine alkaline phosphatase (Roche) overnight at
30°C, followed by resolution by SDS-PAGE and Western
blot with the same antibody.
Apoptosis inhibition assay
Recombinant proteins were added to interphase egg
extracts at 10 μg/ml, and apoptotic nuclear fragmentation
was observed as previously described [11].
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